TGFB1 and neoplasm: CAFs are activated by soluble factors in the tumor proximity, such as TGF-β, and in turn release abundant tumor-promoting and angiogenic factors, thus contributing to the establishment of a refractory TME, tumor growth, and disease progression [33].